DANIELLE ELAM: Open Payments
NPI 1962001255 · HINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 28 payments from 12 companies in 2025. Trend: 2023 $832 · 2024 $533 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $139 |
| Lilly USA, LLC | 5 | $88 |
| PFIZER INC. | 2 | $40 |
| Amgen Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
Products named: MOUNJARO, Ozempic, Wegovy, Rybelsus, PREVNAR 20, XIFAXAN, FANAPT, KRYSTEXXA.
Industry payments across GA — which companies pay providers there.
